Nurexone Biologic Inc
OTC:NRXBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nurexone Biologic Inc
OTC:NRXBF
|
CA |
|
V
|
Vinci SA
F:SQU
|
FR |
|
Shiseido Co Ltd
TSE:4911
|
JP |
|
N
|
Nippon Yusen KK
F:NYKA
|
JP |
|
Toyota Motor Corp
TSE:7203
|
JP |
|
S
|
Stabilis Solutions Inc
F:QAT2
|
US |
|
P
|
Palo Alto Networks Inc
F:5AP
|
US |
|
R
|
Ryman Hospitality Properties Inc
F:4RH
|
US |
|
T
|
Tokyo Electron Ltd
OTC:TOELF
|
JP |
|
M
|
Marathon Petroleum Corp
XETRA:MPN
|
US |
|
Xperi Holding Corp
LSE:0M2A
|
US |
|
C
|
CITIC Securities Co Ltd
OTC:CIIHF
|
CN |
|
Comfort Systems USA Inc
NYSE:FIX
|
US |
|
U
|
Universal Health Services Inc
F:UHS
|
US |
|
A
|
Avnet Inc
F:VNI
|
US |
Bankruptcy Probability
Nurexone Biologic Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Nurexone Biologic Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Nurexone Biologic Inc
F:J90
|
22.4m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
279.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
100.7B ZAR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
79.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
57.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
63.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
G
|
Galderma Group AG
SIX:GALD
|
39.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Symbotic Inc
NASDAQ:SYM
|
31.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Nurexone Biologic Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Nurexone Biologic Inc has total debt of 70k USD. This includes both short-term (0 USD) and long-term (70k USD) debt.
You can find a full breakdown on its Balance Sheet.
